Labcorp Holdings Inc. (LH)
The price, the headline numbers and the latest news, in one place.
Labcorp Holdings Inc. (LH) Stock Price, Analysis & Data
| Bid | 333.33 |
| Market Cap | 27.1B |
| Revenue (ttm) | 14.3B |
| Net Income (ttm) | 1B |
| 0.84 | |
| 12.11 | |
| 27.55 | |
| 16.83 | |
| P/B (ttm) | 3.14 |
| P/S (ttm) | 1.89 |
| Earnings Date | Nov 3, 2026 |
| Ask | 333.6 |
| Volume | 122,458 |
| Avg. Volume (20D) | 674,685 |
| Open | 333.47 |
| Previous Close | 331.66 |
| Day's Range | 330.60 - 335.51 |
| 52-Week Range | 244.52 - 341.80 |
| Analyst | Buy |
| Price Target | 350 (4.9%) |
| Dividends | $2.88 (0.88%) |
| Ex-Dividend Date | Aug 28, 2026 |
About LH
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialt...
Financial Performance
In 2025, Labcorp s's revenue was 13.95B, an increase of 7.25% compared to the previous year's 13.01B. Earnings were 876.5M, an increase of 17.49%.
Financial StatementsAnalyst Forecast
According to 16 analyst ratings, the average rating for LH stock is "Buy". The 12-month stock price forecast is 350, which is upside of 4.9% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $3.73B misses estimates by $0, with 5.78% YoY growth.
- EPS of 4.99 exceeds estimates by 0.22, with 14.71% YoY growth.
Analysts project revenue of ... Upgrade
